Australia markets closed

AngioDynamics, Inc. (ANGO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.79-0.03 (-0.52%)
At close: 04:00PM EDT
5.79 0.00 (0.00%)
After hours: 06:13PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 231.92M
Enterprise value 179.06M
Trailing P/E N/A
Forward P/E 96.15
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.71
Price/book (mrq)1.06
Enterprise value/revenue 0.55
Enterprise value/EBITDA -5.11

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-33.22%
S&P500 52-week change 323.10%
52-week high 311.38
52-week low 35.26
50-day moving average 35.91
200-day moving average 36.87

Share statistics

Avg vol (3-month) 3524.64k
Avg vol (10-day) 3443.43k
Shares outstanding 540.05M
Implied shares outstanding 640.05M
Float 838.89M
% held by insiders 15.00%
% held by institutions 191.25%
Shares short (15 Apr 2024) 42.18M
Short ratio (15 Apr 2024) 43.05
Short % of float (15 Apr 2024) 46.96%
Short % of shares outstanding (15 Apr 2024) 45.44%
Shares short (prior month 15 Mar 2024) 42.46M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 May 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin -59.37%
Operating margin (ttm)-19.28%

Management effectiveness

Return on assets (ttm)-4.81%
Return on equity (ttm)-62.42%

Income statement

Revenue (ttm)324.01M
Revenue per share (ttm)8.10
Quarterly revenue growth (yoy)-6.90%
Gross profit (ttm)N/A
EBITDA -4.92M
Net income avi to common (ttm)-192.37M
Diluted EPS (ttm)-4.80
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)78.45M
Total cash per share (mrq)1.96
Total debt (mrq)3.97M
Total debt/equity (mrq)1.81%
Current ratio (mrq)2.29
Book value per share (mrq)5.41

Cash flow statement

Operating cash flow (ttm)-17.2M
Levered free cash flow (ttm)33.29M